Country |
|
Amphetamine | |||
|---|---|---|---|---|---|
Sample size |
Min. |
Max. |
Ave. | ||
Belgium |
(1) |
179 |
0.5 |
100 |
30.5 |
Czech Republic |
(2) |
150 |
50 |
75 |
62.5 |
Denmark |
(3) |
|
2 |
34 |
9 |
Germany |
(4) |
1430 |
|
|
7.5 |
Estonia |
|
415 |
1 |
100 |
29 |
France-A |
|
46 |
<10 |
>90 |
25 |
France-B |
|
63 |
1.5 |
72 |
19 |
Latvia |
|
303 |
3 |
91 |
40 |
Lithuania |
(5) |
162 |
1 |
76 |
40 |
Luxembourg |
|
|
6.8 |
30.75 |
15.8 |
Hungary |
|
534 |
2 |
55 |
15 |
Malta |
|
|
20 |
50 |
40 |
Netherlands-B |
|
345 |
|
73 |
33.1 |
Netherlands-C |
|
12 |
|
66 |
17.7 |
Austria |
|
|
1 |
99 |
10 |
Poland |
|
701 |
2 |
99 |
30-50 |
Slovakia |
(6) |
172 |
1.8 |
80 |
49 |
Finland |
|
600 |
2.8 |
98 |
35 |
United Kingdom |
|
1392 |
0.02 |
74 |
10.8 |
Norway |
|
440 |
1 |
98 |
50 |
Notes: Min = minimum purity recorded; Max = maximum purity recorded; Ave = average purity recorded. Data were not available in 2003 for the un-listed EU member states. (1) Both amphetamine and methamphetamine and combinations of the two are counted. There were 167 samples containing only amphetamine, 5 samples containing only methamphetamine and 7 samples that contained both. For the statistics, only the percentage of amphetamine is counted. (2) Figures refer to methamphetamine (pervitin); figures reported as averages are actually middle points between minimum and maximum purities. (3) Figures reported as averages refer to median values. (4) Figures reported as averages refer to mode values. (5) There is also data available for methamphetamine: sample size 432; min. 2; max. 69; average 40. (6) Figures refer to methamphetamine. Source: Reitox national focal points see [Table PPP-8 part (ii)]. | |||||